7GA-21150-77692
2 vaccinations
7 coded responses
24 check-ins
7 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 497 / MI
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-28
Registered in v-safe
-
2021-01-28
Dose 1 — Pfizer-BioNTech
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-11
- 2021-02-18
-
2021-02-19
Dose 2 — Pfizer-BioNTech
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-22
- 2021-02-23
- 2021-02-24
-
2021-02-25
Survey response — days 1–6 daily, dose 2MedDRA: Paraesthesia — Feeling: Good · Fatigue or tirednessFree text: Tingling in arm with inocyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Survey response — day 7, dose 2MedDRA: Paraesthesia — Feeling: Good · Fatigue or tirednessFree text: Tingling in arm with inoculationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Survey response — day 14, dose 2MedDRA: Fatigue, Hypoaesthesia, Malaise, Paraesthesia — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Still have numbness/tingling in my left (inoculation) arm, and still have significant fatigue. Also feel generally ill, but no respiratory issues.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Report sent to call center — day 14, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-12
Survey response — day 21, dose 2MedDRA: Muscular weakness, Sensitive skin — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Continuing sensitivity in left arm and overall muscle weakness.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — day 28, dose 2MedDRA: Hospitalisation, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Hospitalized with transverse myelitis.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Survey response — day 35, dose 2MedDRA: Emergency care, Hospitalisation, Myelitis transverse — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Hospitalized with transverse myelitis, with follow-up visit to ER due to lack of steroid tapering.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Report sent to call center — day 35, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-02
- 2021-05-21
-
2021-08-22
Survey response — 6 months, dose 2MedDRA: Myelitis transverse — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Continuing to deal with Transverse Myelitis, as I have reported (apparently to no effect) each time I was contacted following the onset of the symptoms. If I hear nothing in response to this note, Ill assume it is not being monitored.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-22
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-25
-
2021-08-30
Call successfulReported to VAERS voluntarily prior to GDIT contact
- 2022-02-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech |
Call center
3 call center cases
3 successful
VAERS report filed, before or during a call: 1
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Tingling in arm with inocy
Release 4 — day 7, dose 2
Systemic reaction (other): Tingling in arm with inoculation
Release 5 — day 14, dose 2
Symptoms: Still have numbness/tingling in my left (inoculation) arm, and still have significant fatigue. Also feel generally ill, but no respiratory issues.
Release 5 — day 21, dose 2
Symptoms: Continuing sensitivity in left arm and overall muscle weakness.
Release 5 — day 28, dose 2
Symptoms: Hospitalized with transverse myelitis.
Release 6 — day 35, dose 2
Symptoms: Hospitalized with transverse myelitis, with follow-up visit to ER due to lack of steroid tapering.
Release 9 — 6 months, dose 2
Symptoms: Continuing to deal with Transverse Myelitis, as I have reported (apparently to no effect) each time I was contacted following the onset of the symptoms. If I hear nothing in response to this note, Ill assume it is not being monitored.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Emergency care | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hospitalisation | ✓ | ✓ | ✓ |
| SD | Hypoaesthesia | ✓ | ✓ | ✓ |
| SD | Malaise | ✓ | ✓ | ✓ |
| SD | Muscular weakness | ✓ | ✓ | ✓ |
| SD | Myelitis transverse | ✓ | ✓ | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Sensitive skin | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release